{
  "id": 2091,
  "text": "All patients enrolled were younger than 45 years of age and had FIGO stage I/II disease treated with surgery or radiotherapy.After treatment, no significant difference in DFS or OS at 5 years was noted betweeen patients treated with HRT and controls.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: All patients enrolled were younger than 45 years of age and had FIGO stage I/II disease treated with surgery or radiotherapy.After treatment, no significant difference in DFS or OS at 5 years was noted betweeen patients treated with HRT and controls.\n\n<question>: ",
  "ChatGPT_response_0": "根据这项研究结果显示，在年龄不到45岁且患有手术或放疗治疗的FIGO第I/II期疾病的患者中，使用激素替代治疗（HRT）与控制组相比，未显示出在疾病自由生存期（DFS）或总生存期（OS）方面有显著差异。因此，对于这个年龄段的患者，是否应该考虑使用激素替代治疗需要更多的研究和讨论。在决定是否给予患者激素替代治疗时，应结合患者的个体情况、病情严重程度以及潜在的风险和好处进行综合评估，同时需在医生和患者之间充分沟通和共同决策。",
  "query": "所有入选的患者年龄都不到45岁，并且患有手术或放疗治疗的FIGO第I/II期疾病。治疗后，五年内接受激素替代治疗（HRT）和控制组患者的疾病自由生存期（DFS）或总生存期（OS）没有显著差异。在这个研究中，您认为青年患者接受手术或放疗后是否应该考虑使用激素替代治疗呢？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 所有入选的患者年龄都不到45岁，并且患有手术或放疗治疗的FIGO第I/II期疾病。治疗后，五年内接受激素替代治疗（HRT）和控制组患者的疾病自由生存期（DFS）或总生存期（OS）没有显著差异。在这个研究中，您认为青年患者接受手术或放疗后是否应该考虑使用激素替代治疗呢？\n\n<reference text>: All patients enrolled were younger than 45 years of age and had FIGO stage I/II disease treated with surgery or radiotherapy.After treatment, no significant difference in DFS or OS at 5 years was noted betweeen patients treated with HRT and controls.\n\n<reply>: ",
  "response": "根据这项研究结果显示，在年龄不到45岁且患有手术或放疗治疗的FIGO第I/II期疾病的患者中，使用激素替代治疗（HRT）与控制组相比，未显示出在疾病自由生存期（DFS）或总生存期（OS）方面有显著差异。因此，对于这个年龄段的患者，是否应该考虑使用激素替代治疗需要更多的研究和讨论。在决定是否给予患者激素替代治疗时，应结合患者的个体情况、病情严重程度以及潜在的风险和好处进行综合评估，同时需在医生和患者之间充分沟通和共同决策。"
}